FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2308589342> ?p ?o ?g. }

• W2308589342 abstract "High breast density is linked to an increased risk of breast cancer, and correlates with changes in collagen. In a mouse model of mammary carcinoma in the context of increased collagen deposition, the MMTV-PyMT/Col1a1 tm1jae , there is accelerated mammary tumor formation and progression. Previous gene expression analysis suggests that increased collagen density elevates expression of PTGS2 (prostaglandin-endoperoxide synthase 2), the gene for cyclooxygenase-2 (COX-2). To understand the role of COX-2 in tumor progression within a collagen-dense microenvironment, we treated MMTV-PyMT or MMTV-PyMT/Col1a1 tm1jae tumors prior to and after tumor formation. Animals received treatment with celecoxib, a specific COX-2 inhibitor, or placebo. Mammary tumors were examined for COX-2, inflammatory and stromal cell components, and collagen deposition through immunohistochemical analysis, immunofluorescence, multiplex cytokine ELISA and tissue imaging techniques. PyMT/Col1a1 tm1jae tumors were larger, more proliferative, and expressed higher levels of COX-2 and PGE2 than PyMT tumors in wild type (WT) mice. Treatment with celecoxib significantly decreased the induced tumor size and metastasis of the PyMT/Col1a1 tumors, such that their size was not different from the smaller PyMT tumors. Celecoxib had minimal effect on the PyMT tumors. Celecoxib decreased expression levels of COX-2, PGE2, and Ki-67. Several cytokines were over-expressed in PyMT/Col1a1 compared to PyMT, and celecoxib treatment prevented their over-expression. Furthermore, macrophage and neutrophil recruitment were enhanced in PyMT/Col1a1 tumors, and this effect was inhibited by celecoxib. Notably, COX-2 inhibition reduced overall collagen deposition. Finally, when celecoxib was used prior to tumor formation, PyMT/Col1a1 tumors were fewer and smaller than in untreated animals. These findings suggest that COX-2 has a direct role in modulating tumor progression in tumors arising within collagen-dense microenvironments, and suggest that COX-2 may be an effective therapeutic target for women with dense breast tissue and early-stage breast cancer." @default.
• W2308589342 created "2016-06-24" @default.
• W2308589342 creator A5002848732 @default.
• W2308589342 creator A5015163918 @default.
• W2308589342 creator A5016078512 @default.
• W2308589342 creator A5021547013 @default.
• W2308589342 creator A5027244347 @default.
• W2308589342 creator A5053434770 @default.
• W2308589342 creator A5062418760 @default.
• W2308589342 date "2016-03-22" @default.
• W2308589342 modified "2023-10-17" @default.
• W2308589342 title "COX-2 modulates mammary tumor progression in response to collagen density" @default.
• W2308589342 cites W1239567665 @default.
• W2308589342 cites W1574620960 @default.
• W2308589342 cites W1935309503 @default.
• W2308589342 cites W1962449772 @default.
• W2308589342 cites W1968728403 @default.
• W2308589342 cites W1982248155 @default.
• W2308589342 cites W1982273913 @default.
• W2308589342 cites W1995388182 @default.
• W2308589342 cites W1997160355 @default.
• W2308589342 cites W2000102677 @default.
• W2308589342 cites W2028663407 @default.
• W2308589342 cites W2030818692 @default.
• W2308589342 cites W2030987066 @default.
• W2308589342 cites W2031491948 @default.
• W2308589342 cites W2036680234 @default.
• W2308589342 cites W2039430775 @default.
• W2308589342 cites W2042033090 @default.
• W2308589342 cites W2042037797 @default.
• W2308589342 cites W2051135482 @default.
• W2308589342 cites W2060530444 @default.
• W2308589342 cites W2062809449 @default.
• W2308589342 cites W2070732038 @default.
• W2308589342 cites W2072000804 @default.
• W2308589342 cites W2079766507 @default.
• W2308589342 cites W2089258206 @default.
• W2308589342 cites W2090203203 @default.
• W2308589342 cites W2096410299 @default.
• W2308589342 cites W2098045968 @default.
• W2308589342 cites W2100122781 @default.
• W2308589342 cites W2101728107 @default.
• W2308589342 cites W2104479723 @default.
• W2308589342 cites W2104607769 @default.
• W2308589342 cites W2111449140 @default.
• W2308589342 cites W2125066552 @default.
• W2308589342 cites W2125381755 @default.
• W2308589342 cites W2136737404 @default.
• W2308589342 cites W2140374399 @default.
• W2308589342 cites W2141806195 @default.
• W2308589342 cites W2141937355 @default.
• W2308589342 cites W2142820137 @default.
• W2308589342 cites W2145149010 @default.
• W2308589342 cites W2147339810 @default.
• W2308589342 cites W2149639441 @default.
• W2308589342 cites W2162407837 @default.
• W2308589342 cites W2166454331 @default.
• W2308589342 cites W2330709704 @default.
• W2308589342 cites W2336215030 @default.
• W2308589342 cites W2917423152 @default.
• W2308589342 cites W4238996943 @default.
• W2308589342 doi "https://doi.org/10.1186/s13058-016-0695-3" @default.
• W2308589342 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4802888" @default.
• W2308589342 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27000374" @default.
• W2308589342 hasPublicationYear "2016" @default.
• W2308589342 type Work @default.
• W2308589342 sameAs 2308589342 @default.
• W2308589342 citedByCount "91" @default.
• W2308589342 countsByYear W23085893422016 @default.
• W2308589342 countsByYear W23085893422017 @default.
• W2308589342 countsByYear W23085893422018 @default.
• W2308589342 countsByYear W23085893422019 @default.
• W2308589342 countsByYear W23085893422020 @default.
• W2308589342 countsByYear W23085893422021 @default.
• W2308589342 countsByYear W23085893422022 @default.
• W2308589342 countsByYear W23085893422023 @default.
• W2308589342 crossrefType "journal-article" @default.
• W2308589342 hasAuthorship W2308589342A5002848732 @default.
• W2308589342 hasAuthorship W2308589342A5015163918 @default.
• W2308589342 hasAuthorship W2308589342A5016078512 @default.
• W2308589342 hasAuthorship W2308589342A5021547013 @default.
• W2308589342 hasAuthorship W2308589342A5027244347 @default.
• W2308589342 hasAuthorship W2308589342A5053434770 @default.
• W2308589342 hasAuthorship W2308589342A5062418760 @default.
• W2308589342 hasBestOaLocation W23085893421 @default.
• W2308589342 hasConcept C121608353 @default.
• W2308589342 hasConcept C126322002 @default.
• W2308589342 hasConcept C134018914 @default.
• W2308589342 hasConcept C142724271 @default.
• W2308589342 hasConcept C185592680 @default.
• W2308589342 hasConcept C2776107976 @default.
• W2308589342 hasConcept C2776187077 @default.
• W2308589342 hasConcept C2776467144 @default.
• W2308589342 hasConcept C2779013556 @default.
• W2308589342 hasConcept C2779256057 @default.
• W2308589342 hasConcept C502942594 @default.
• W2308589342 hasConcept C530470458 @default.
• W2308589342 hasConcept C71924100 @default.
• W2308589342 hasConceptScore W2308589342C121608353 @default.
• W2308589342 hasConceptScore W2308589342C126322002 @default.

• next